CUAMC
CSTL icon

China Universal Asset Management Company’s Castle Biosciences CSTL Stock Holding History

China Universal Asset Management Company’s Portfolio CSTL Stock Details CSTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$115K Sell
4,827
-449
-9% -$10K 0.01% 403
2026
Q1 		$130K Buy
5,276
+520
+11% +$17K 0.01% 386
2025
Q4 		$185K Sell
4,756
-329
-6% -$10.6K 0.01% 351
2025
Q3 		$116K Sell
5,085
-714
-12% -$14.5K 0.01% 375
2025
Q2 		$118K Buy
5,799
+80
+1% +$1.48K 0.01% 351
2025
Q1 		$114K Sell
5,719
-220
-4% -$5.45K 0.01% 350
2024
Q4 		$158K Buy
5,939
+604
+11% +$18.4K 0.01% 344
2024
Q3 		$152K Buy
5,335
+2,093
+65% +$53.3K 0.02% 320
2024
Q2 		$70.6K Sell
3,242
-2,055
-39% -$45.8K 0.01% 330
2024
Q1 		$117K Buy
5,297
+2,187
+70% +$47.6K 0.01% 354
2023
Q4 		$67.1K Buy
3,110
+2,421
+351% +$42.6K 0.01% 333
2023
Q3 		$11.6K Buy
689
+339
+97% +$5.93K ﹤0.01% 339
2023
Q2 		$4.8K Sell
350
-10
-3% -$203 ﹤0.01% 373
2023
Q1 		$8.18K Buy
360
+92
+34% +$2.25K ﹤0.01% 319
2022
Q4 		$6.31K Buy
268
+22
+9% +$510 ﹤0.01% 267
2022
Q3 		$6K Buy
+246
New +$6.9K ﹤0.01% 248

Other funds holding CSTL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.79B AUM 30.56% 1-Year Est. Return
ACM
Advisors Capital Management Ridgewood, New Jersey $9.45B AUM 27.66% 1-Year Est. Return

China Universal Asset Management Company's CSTL Position: Q2 2026 in Review

China Universal Asset Management Company reduced its Castle Biosciences (CSTL) stake by 8.5% in Q2 2026, selling an estimated $10K and leaving 4,827 shares worth $115K. The position accounts for 0.01% of the portfolio, ranked #403.

China Universal Asset Management Company first reported a position in CSTL in Q3 2022 and has held it in 16 quarters since. The position peaked at $185K in Q4 2025. 94 funds tracked by Wall St. Rank hold CSTL as of Q2 2026.

  • China Universal Asset Management Company held 4,827 shares of Castle Biosciences worth $115K as of Q2 2026.
  • China Universal Asset Management Company sold 449 Castle Biosciences shares in Q2 2026, an estimated $10K.
  • Castle Biosciences made up 0.01% of China Universal Asset Management Company's portfolio in Q2 2026, its #403 holding.
  • China Universal Asset Management Company first reported a position in Castle Biosciences in Q3 2022 and has held it in 16 quarters since.
  • China Universal Asset Management Company's Castle Biosciences position peaked at $185K in Q4 2025.
  • 94 funds tracked by Wall St. Rank held Castle Biosciences as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.